147
Views
13
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse

, , , , , , , , & show all
Pages 214-222 | Received 15 Oct 2010, Accepted 04 Nov 2010, Published online: 10 Dec 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Nina Orfali, Yuliya Jhanwar, Calvin Koo, Michelle Pasciolla, Maria Baldo, Edwidge Cuvilly, Richard Furman, Usama Gergis, June Greenberg, Danielle Guarneri, Jing-Mei Hsu, John P. Leonard, Tomer Mark, Sebastian Mayer, Kathleen Maignan, Peter Martin, Adomah Opong, Roger Pearse, Adrienne Phillips, Adriana Rossi, Jia Ruan, Sarah C. Rutherford, Jessy Ryan, Grace Suhu, Koen Van Besien & Tsiporah Shore. (2021) Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma. Leukemia & Lymphoma 62:7, pages 1629-1638.
Read now
Craig S. Sauter, Joanne F. Chou, Esperanza B. Papadopoulos, Miguel-Angel Perales, Ann A. Jakubowski, James W. Young, Michael Scordo, Sergio Giralt & Hugo Castro-Malaspina. (2014) A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies. Leukemia & Lymphoma 55:12, pages 2739-2747.
Read now
Xavier Poiré & Koen van Besien. (2011) Alemtuzumab in allogeneic hematopoetic stem cell transplantation. Expert Opinion on Biological Therapy 11:8, pages 1099-1111.
Read now

Articles from other publishers (10)

Sebastian Mayer & Koen van Besien. 2017. Hematopoietic Cell Transplants. Hematopoietic Cell Transplants 232 246 .
. 2017. Hematopoietic Cell Transplants. Hematopoietic Cell Transplants 201 246 .
Prathima Anandi, Xin Tian, Sawa Ito, Pawel Muranski, Puja D. Chokshi, Noelle Watters, Upneet Chawla, Nancy Hensel, David F. Stroncek, Minoo Battiwalla & A. John Barrett. (2017) Ex vivo T-cell–depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy. Cytotherapy 19:6, pages 735-743.
Crossref
Koen van Besien. (2015) Allografting versus Autografting for Follicular Lymphoma: An Ongoing Conundrum. Biology of Blood and Marrow Transplantation 21:12, pages 2035-2036.
Crossref
Satyajit Kosuri & Koen Van Besien. 2015. Clinical Guide to Transplantation in Lymphoma. Clinical Guide to Transplantation in Lymphoma 119 131 .
Mehdi Hamadani, Wael Saber, Kwang Woo Ahn, Jeanette Carreras, Mitchell S. Cairo, Timothy S. Fenske, Robert Peter Gale, John Gibson, Gregory A. Hale, Parameswaran N. Hari, Jack W. Hsu, David J. Inwards, Rammurti T. Kamble, Anderas Klein, Dipnarine Maharaj, David I. Marks, David A. Rizzieri, Bipin N. Savani, Harry C. Schouten, Edmund K. Waller, Baldeep Wirk, Ginna G. Laport, Silvia Montoto, David G. Maloney & Hillard M. Lazarus. (2013) Impact of Pretransplantation Conditioning Regimens on Outcomes of Allogeneic Transplantation for Chemotherapy-Unresponsive Diffuse Large B Cell Lymphoma and Grade III Follicular Lymphoma. Biology of Blood and Marrow Transplantation 19:5, pages 746-753.
Crossref
Koen van Besien, Wendy Stock, Elizabeth Rich, Olatoyosi Odenike, Lucy A. Godley, Peter H. O’Donnell, Justin Kline, Vu Nguyen, Paula del Cerro, Richard A. Larson & Andrew S. Artz. (2012) Phase I-II Study of Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 18:6, pages 913-921.
Crossref
Koen van Besien. (2011) Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma. Current Opinion in Oncology 23:6, pages 681-691.
Crossref
Ron Ram, Ted A. Gooley, David G. Maloney, Oliver W. Press, John M. Pagel, Stephen H. Petersdorf, Andrei R. Shustov, Mary E.D. Flowers, Paul O’Donnell, Brenda M. Sandmaier, Rainer F. Storb & Ajay K. Gopal. (2011) Histology and Time to Progression Predict Survival for Lymphoma Recurring after Reduced-Intensity Conditioning and Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 17:10, pages 1537-1545.
Crossref
Kitsada Wudhikarn, Claudio G. Brunstein, Veronika Bachanova, Linda J. Burns, Qing Cao & Daniel J. Weisdorf. (2011) Relapse of Lymphoma after Allogeneic Hematopoietic Cell Transplantation: Management Strategies and Outcome. Biology of Blood and Marrow Transplantation 17:10, pages 1497-1504.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.